We provide the reader with relevant data related to our recently published paper, comparing two mathematical models to describe prolactin turnover in rats following one or two doses of the dopamine D 2 receptor antagonists risperidone, paliperidone and remoxipride, "A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D 2 receptor antagonists in rats" (Taneja et al., 2016) [1].
a b s t r a c t
We provide the reader with relevant data related to our recently published paper, comparing two mathematical models to describe prolactin turnover in rats following one or two doses of the dopamine D 2 receptor antagonists risperidone, paliperidone and remoxipride, "A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D 2 receptor antagonists in rats" (Taneja et al., 2016) [1] . All information is tabulated. Summary level data on the in vitro potencies and the physicochemical properties is presented in Table 1 . Model parameters required to explore the precursor pool model are presented in Table 2 . In Table 3 , estimated parameter comparisons for both models are
Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dib presented, when separate potencies are estimated for risperidone and paliperidone, as compared to a common potency for both drugs. In Table 4 
Value of the data

Data can be used
To compare experimental findings in literature with our model-based approach. As prior information, especially when the available data is scarce. For exploratory modeling. For translation from rat to humans.
Data
The information is presented in 4 tables. Table 1 presents the in vitro inhibition constant (KI) values in rat and humans and physicochemical characteristics of the antipsychotics risperidone, paliperidone and remoxipride. Table 2 presents the pharmacokinetic-pharmacodynamic model Table 2 Model parameters used for the simulations in exploratory model analysis. Pharmacokinetic and pharmacodynamic parameters obtained from Kozielska et al. [3] and Stevens et al. [4] , respectively.
Parameter
Estimate
CL ¼ clearance from the central compartment, V1 ¼ volume of the central compartment, Q ¼ intercompartmental clearance, V2 ¼ volume of the peripheral compartment, F ¼ bioavailability, Ka ¼ absorption constant, C prl,0 ¼ plasma concentration of prolactin in the absence of antipsychotic drug, R form ¼ zero-order rate constant for prolactin synthesis, K base ¼ first-order rate constant of prolactin release from the pool, K out ¼ first-order rate constant of elimination of prolactin from plasma, E max ¼ maximum increase in the prolactin release from the pool, EC 50 ¼ drug concentration at half-maximal effect, γ ¼ slope parameter, E max_pf ¼ maximum prolactin feedback, EC 50_pf ¼ plasma prolactin concentration at half-maximal effect. n R form is calculated as the product of C prl,0 . K out (equation (5) of Taneja et al. [1] ). parameters used to perform exploratory model simulations of the precursor pool model, as referred to in Section 3.2, Fig. 5 of Taneja et al. [1] . Table 3 presents the model parameters assuming equal or different potency of risperidone and paliperidone. Table 4 presents the model parameters obtained with different parameterizations, assuming either unbound drug concentration or dopamine D 2 receptor occupancy as the driving force for drug effect.
Experimental design, materials and methods
Details of the experimental procedures have been described previously [1, 5, 6] . 
